MatthewDavidRingelMD
Endocrinology • Columbus, OHDiabetes, Lipid Metabolism, Thyroid
Professor, Internal Medicine, Ohio State University College of Medicine
Dr. Ringel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2050 Kenny Rd
Fl 10
Columbus, OH 43221Phone+1 614-685-3333Fax+1 614-685-3335
Education & Training
Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1994 - 1997
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1991 - 1994
Pennsylvania State University College of MedicineClass of 1991
Certifications & Licensure
OH State Medical License 2003 - 2026
DC State Medical License 1997 - 2004
VA State Medical License 1993 - 2000- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 252 citationsPerformance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.David L. Steward, Sally E. Carty, Rebecca S. Sippel, Samantha Peiling Yang, Julie Ann Sosa
JAMA Oncology. 2019-02-01 - 4 citationsClinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy.M D Ringel, W F Schwindinger, M A Levine
Medicine. 1996-07-01 - 74 citationsAKT in thyroid tumorigenesis and progression.Motoo Shinohara, Yun Jae Chung, Motoyasu Saji, Matthew D. Ringel
Endocrinology. 2007-03-01
Press Mentions
Could Blockbuster Weight Loss Drugs Also Be Used to Treat Heart Disease, Alzheimer’s, and Cancer?January 11th, 2024
Grant Support
- RCAN1 In Thyroid Cancer ProgressionNational Cancer Institute2011–2012
- P21 Activated Kinases And EMT In Thyroid CancerNational Cancer Institute2008–2012
- Genetic And Signaling Pathways In Epithelial Thyroid CancerNational Cancer Institute2008–2012
- Administration And BudgetingNational Cancer Institute2008–2012
- AKT Intracellular Localization In Thyroid CancerNational Cancer Institute2005–2009
- Anti-Metastatic Effect Of MCIP1 In Thyroid CancerNational Cancer Institute2005–2006
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
